EUVIMEDEUVIMED entdecken
Crossref

Predicting the Dynamic Viscosity of High-Concentration Antibody Solutions with a Chemically Specific Coarse-Grained Model

Tobias M Prass iD, Patrick Garidel iD, Michaela Blech, Lars V Schäfer iD

The Journal of Physical Chemistry Letters · 2025

DOI: 10.1021/acs.jpclett.5c03003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry Letters, 2025. Verfasst von Tobias M Prass und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Theoretical Chemistry, Ruhr University Bochum, D-44780 Bochum, Germany. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Omalizumab, Antibodies, Monoclonal. Die Arbeit nennt 61 Literaturangaben. Gefördert von: K?benhavns Universitet, Deutsche Forschungsgemeinschaft, Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The viscosity of high-concentration protein solutions is a critical parameter in biopharmaceutical formulation development. Conventionally, the viscosity is measured and optimized in labor-intensive experimental workflows that require a lot of material. While predicting the viscosity with atomistic molecular dynamics (MD) simulations is feasible, they are computationally prohibitively expensive due to the large system sizes and the long simulation times involved. Coarse-grained MD (CG-MD) simulations significantly reduce computational demands, but evaluating their accuracy and predictive power requires rigorous validation. Here, we assess the capability of the Martini 3 CG force field to predict the viscosity of high-concentration antibody solutions. We show that a refined Martini 3 force field, with optimized protein-protein interactions, can predict the elevated viscosities observed in concentrated solutions of F(ab')2 fragments of the therapeutic monoclonal antibody (mAb) omalizumab. Furthermore, we show that our previously developed Martini 3-exc model for arginine excipients successfully captures the trend of lowering viscosity, as observed in our rheology experiments. These findings open the way to physics-based computational prediction of the properties of dense biopharmaceutical solutions via large-scale MD simulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationOmalizumabAntibodies, MonoclonalViscositySolutions

Substanzen

SolutionsOmalizumabAntibodies, Monoclonal

Autor:innen und Institutionen

  • Center for Theoretical Chemistry, Ruhr University Bochum, D-44780 Bochum, Germany.
  • Innovation Unit, Pharmaceutical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, D-88397 Biberach an der Riss, Germany.
  • Innovation Unit, Analytical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, D-88397 Biberach an der Riss, Germany.

ORCID-Profile: Tobias M Prass, Patrick Garidel, Lars V Schäfer

Förderung

  • K?benhavns Universitet
  • Deutsche Forschungsgemeinschaft
  • Boehringer Ingelheim

Zitieren

APA

Prass, T. M., Garidel, P., Blech, M., & Schäfer, L. V. (2025). Predicting the Dynamic Viscosity of High-Concentration Antibody Solutions with a Chemically Specific Coarse-Grained Model. The Journal of Physical Chemistry Letters. https://doi.org/10.1021/acs.jpclett.5c03003

Vancouver

Prass TM, Garidel P, Blech M, Schäfer LV. Predicting the Dynamic Viscosity of High-Concentration Antibody Solutions with a Chemically Specific Coarse-Grained Model. The Journal of Physical Chemistry Letters. 2025. doi:10.1021/acs.jpclett.5c03003

BibTeX
@article{Prass2025,
  author = {Prass, Tobias M and Garidel, Patrick and Blech, Michaela and Schäfer, Lars V},
  title = {Predicting the Dynamic Viscosity of High-Concentration Antibody Solutions with a Chemically Specific Coarse-Grained Model},
  journal = {The Journal of Physical Chemistry Letters},
  year = {2025},
  doi = {10.1021/acs.jpclett.5c03003}
}
Kostenlos starten →